SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Revolution Medicines Reports Q3 Revenue of $197.6M

RVMD
SquawkNews Desk 1 updates Updated Nov 04, 2026, 09:10 PM UTC

Story updates

09:10:02 PM UTC
SquawkNews
Revolution Medicines reported $197.6M in RASONQUE net product revenue for Q3 2026, reflecting approximately five weeks of U.S. commercial availability; no prior-period comparison was provided. The company reported a $407.5M net loss versus $305.2M in Q3 2025 and reiterated 2026 operating expense gu…

Related stories

Cathay Pacific Orders 14 Airbus Aircraft Cathay Pacific ordered 14 Airbus aircraft to expand its fleet. L impact | EQUITY | Nov 11, 2026, 05:47 AM UTC IndiGo shares climb 4.3% to near one-year high IndiGo rose 4.3% to 5,661.20 rupees as crude prices fell. M impact | EQUITY | Nov 11, 2026, 05:37 AM UTC KKR Acquires 50% Stakes in Vanguard West and Vanguard East KKR has acquired a 50% equity stake in each of Vanguard West and Vanguard East, RWE AG says. M impact | EQUITY | Nov 11, 2026, 05:31 AM UTC Asian session market picture: S&P 500 +0.66%, Nasdaq 100 +1.4%; USD/JPY +0.02%, WTI +0.28%, 9984 leads volume Asian session market picture. US index futures: S and P futures is up 0.66 percent, Nasdaq futures is up 1.4 percent, Dow futures is up 0.3 percent and Russell futures is up 0.51 p M impact | EQUITY | Nov 11, 2026, 05:30 AM UTC Airbus Wins Firm Order for 14 Additional Aircraft From Cathay Group Airbus received a firm order for 14 additional aircraft from Cathay Group. M impact | EQUITY | Nov 11, 2026, 05:26 AM UTC TSMC Board Approves Up to $1 Billion Investment Plan in Anthropic and OpenAI Taiwan Semiconductor Manufacturing said its board approved plans to invest up to $1 billion in Anthropic and OpenAI. M impact | EQUITY | Nov 11, 2026, 05:23 AM UTC